NCT06376409已完成不适用
A Single-center, Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females With Self-Perceived Thinning Hair
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 181
- 试验地点
- 2
- 主要终点
- The percent change in hair growth rate at Day 180 relative to baseline (Day 0)
研究概览
简要总结
A single site open label interventional study evaluating currently marketed hair supplements targeting the underlying root causes of thinning hair.
详细描述
A single site open label interventional study evaluating currently marketed hair supplements targeting the underlying root causes of thinning hair. All treatment regimens are commercially available nutraceutical hair growth supplements. 45 subjects will be enrolled into each of the 4 supplement groups. Subjects will undergo a baseline, baseline + 48 hours, 90 day, 90 day + 48 hours, 180 day and 180 day + 48 hours visit and will have compliance phone calls at Days 45 and 135. All subject data will be compared to baseline in paired comparison for each subject using a historical control.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 70 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Females of all Fitzpatrick skin, and hair types between 18-70 years of age with self-perceived thinning, confirmed by a dermatologist.
- •Willing and able to adhere to the same dietary lifestyles for the duration of the study.
- •Able to understand and sign an informed consent agreement and photo release form approved by the Institutional Review Board
- •General good health, as determined by the Investigator or qualified sub-investigator.
- •Willing and able to attend all study visits and comply with the test product daily instructions.
- •Willing to use a mild non-medicated shampoo and conditioner for the duration of the study (medicated shampoo and conditioner refer to any prescription shampoo or conditioner as well as any over-the counter medicated shampoo or conditioner, such as those for treatment of dandruff or promoting hair growth).
- •Willing and able to cooperate with the requirements of the study.
- •Able to complete and understand the various questionnaires.
排除标准
- •Individuals who are pregnant, planning a pregnancy, nursing, or within 1-year post-partum.
- •Individuals who have experienced serious complications due to COVID-19 previously or during the study as determined by the investigator.
- •Clinical diagnosis of hair loss disorder such as alopecia areata, or scarring forms of alopecia.
- •Individuals who have had a history of any acute or chronic disease that could interfere with or increase the risk on study participation.
- •Individuals who have had a history of any acute or chronic medical or hair condition that could affect study results, such as a history of disordered eating.
- •Scalp hair loss on the treatment area, due to disease, injury, or medical therapy.
- •Current skin disease (e.g., psoriasis, atopic dermatitis, skin cancer, eczema, sun damage, seborrheic dermatitis), infection, cuts, and/ or abrasions on the scalp or condition (e.g., sunburn, tattoos) on the treatment area that, in the opinion of the Investigator or qualified sub-investigator, might put the subject at risk or interfere with the study conduct or evaluations.
- •History of surgical correction of hair loss on the scalp (i.e., hair transplant).
- •Use of any products or devices purported to promote scalp hair growth (e.g., finasteride or minoxidil) within the 6 months prior to the Baseline Visit.
- •Females who have recently (within the last 6 months) started the use of hormones for birth control or hormone replacement therapy (HRT). Women currently using hormones for birth control or HRT must have been on a stable dose (6 months or longer) in order to be eligible for the study (the initiation of HRT or birth control should not have been associated with the initiation of hair loss/thinning).
- •History of malignancy (except cutaneous squamous cell carcinoma and basal cell carcinoma) or currently undergoing chemotherapy or radiation treatments.
- •A known history of autoimmune thyroid disease, any other thyroid disorder/abnormality or other autoimmune disorders that in the opinion of the Investigator or qualified sub-investigator may interfere with the study treatment.
- •A known history of unstable or chronic depression or bipolar disease or any other condition that may impact the subject's participation in the opinion of the investigator or qualified sub-investigator.
- •A known allergy to any of the ingredients in the investigational product.
- •Utilization of low-level lasers for hair growth in the last three months.
- •Any condition that the Investigator thinks may put the subject at risk or interfere with their participation in the study or study results.
- •Known history of or current iron deficiency, bleeding disorders or platelet dysfunction syndrome as well as subjects receiving anticoagulant therapy or smokers with usage >20 cigarettes/day as reported by the subject.
- •Use of any medications or medicated shampoos that are known to potentially cause hair loss or affect hair growth, as determined by the Investigator or qualified sub-investigator.
结局指标
主要结局
The percent change in hair growth rate at Day 180 relative to baseline (Day 0)
时间窗: 180 days
The percent change in hair growth rate at Day 180 relative to baseline (Day 0) using Canfield HairMetrix® non-invasive device.
次要结局
- The change in average number of hairs per follicular unit(180 Days)
- The change in anagen to telogen ratio(180 Days)
- The change in mean inter-follicular distance(180 Days)
- The change in terminal to vellus ratio(180 Days)
- The percent change in hair growth rate at Day 90 relative to baseline (Day 0)(90 Days)
- The change in total hair count, terminal hairs, vellus hairs, anagen, and telogen hairs compared to baseline at 90 days(90 days)
- The change in total hair width per cm2(180 Days)
- Subjective assessments of change measured with Consumer Perception Questionnaire at 90 days(90 Days)
- Subjective assessments of change measured with Consumer Perception Questionnaire at 180 days(180 Days)
- The change in total hair count, terminal hairs, vellus hairs, anagen, and telogen hairs compared to baseline at 180 days(180 days)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
A Single-Group Clinical Trial Investigating the Effects of a Hair Vitamin Combination on Hair Growth and Hair HealthHair HealthHair LossNCT06120933BrandiZone25
进行中（未招募）
不适用
The Effects of an Oral Hair Supplement on Hair Density, Growth, and MicrobiomeHair ThinningNCT06146166Integrative Skin Science and Research60
已完成
不适用
Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen EffluviumHealthyTelogen EffluviumNCT06545552Activ'inside66
已完成
不适用
Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and MenHair ThinningNCT06362941Nutraceutical Wellness Inc.200
Unknown
不适用
Hairstetics Hair Implant Device Safety and EfficacyAlopeciaNCT02856308Hairstetics100